SEC Form 4 · accession 0000911916-16-000678

CoLucid Pharmaceuticals, Inc. · CLCD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Head, Bus. Dev. and Strategy

Period of report

Oct 3, 2016

Accepted (ET)

Oct 5, 2016 · 4:17 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001348649

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Oct 3, 2016	M	719	$6.75	A	719	D
Common Stock^F1	Oct 3, 2016	S	719	$37.74	D	0	D
Common Stock	Oct 4, 2016	M	185	$7.56	A	185	D
Common Stock^F1	Oct 4, 2016	S	185	$36.41	D	0	D
Common Stock	Oct 5, 2016	M	1,677	$10.00	A	1,677	D
Common Stock^F1	Oct 5, 2016	S	1,677	$37.08	D	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F2	$6.75	Oct 3, 2016	M	719	D	—	Mar 4, 2026	Common Stock	719	28,750	D
Stock Option (Right to Buy)^F3	$7.56	Oct 4, 2016	M	185	D	—	Aug 4, 2025	Common Stock	185	6,297	D
Stock Option (Right to Buy)^F4	$10.00	Oct 5, 2016	M	1,677	D	—	May 5, 2025	Common Stock	1,677	51,998	D

F1Securities sold pursuant to a written plan intended to comply with Rule 10b5-1(c)(i) adopted by Ms. Hogan on March 24, 2016.
F2Options vest in a series of 48 successive equal monthly installments with the first monthly installment vesting on the grant date and the future installments vesting on the first day of each calendar month.
F3Options vest as follows: one-third of the shares vested on August 4, 2016; and the remaining shares vest in a series of 36 successive equal monthly installments upon completion of each additional month of service.
F4Options vest as follows: 33% of the shares vested on May 5, 2016; and the remaining shares vest in a series of 36 successive equal monthly installments upon completion of each additional month of service.